Tiziano M. Scarabelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tiziano M. Scarabelli has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Carol Chen-Scarabelli
VA Ann Arbor/University of Michigan Healthcare System, Ann Arbor, MI, USA
1 shared publication - Carol Chen-Scarabelli
VA Ann Arbor Healthcare System, University of Michigan, 2215 Fuller Road (111A), Ann Arbor, MI 48105, USA
1 shared publication
Latest Publications
- 13 March 2007
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 30 (3) , 371-376
Chronic Renal Insufficiency Is an Independent Predictor of Mortality in Implantable Cardioverter‐Defibrillator Recipients
Background: Chronic renal insufficiency (CRI) has been associated with increased risk of cardiovascular morbidity and mortality. However, there is limited knowledge regarding this association and the effect of renal dysfunction on survival benefit in patients with implantable cardioverter‐defibrillators (ICDs). Methods: We investigated whether there was an association between CRI (defined as serum creatinine levels ≥1.5 mg/dL) and increased risk of mortality in ICD recipients. We retrospectively studied all patients (n = 336) followed within our ICD clinic in a 2.5‐year period. CRI, ventricular tachycardia (VT), cardiomyopathy (CM), and mortality were recorded. Ischemic CM was defined as the presence of coronary artery disease (CAD) and left ventricular ejection fraction ≤ 30%. Results: Despite no significant difference in CAD and VT occurrence between CRI and non‐CRI groups in the overall population, there was a significantly higher mortality rate in the CRI group (P < 0.0001). Conclusion: CRI is a significant independent predictor of mortality in ICD recipients. Further investigation is needed to determine whether prevention, early detection, and more aggressive intervention in the treatment of CRI will reduce the incidence of mortality in this population.
- 13 March 2007
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 30 (3) , 371-376
Chronic Renal Insufficiency Is an Independent Predictor of Mortality in Implantable Cardioverter‐Defibrillator Recipients
Background: Chronic renal insufficiency (CRI) has been associated with increased risk of cardiovascular morbidity and mortality. However, there is limited knowledge regarding this association and the effect of renal dysfunction on survival benefit in patients with implantable cardioverter‐defibrillators (ICDs). Methods: We investigated whether there was an association between CRI (defined as serum creatinine levels ≥1.5 mg/dL) and increased risk of mortality in ICD recipients. We retrospectively studied all patients (n = 336) followed within our ICD clinic in a 2.5‐year period. CRI, ventricular tachycardia (VT), cardiomyopathy (CM), and mortality were recorded. Ischemic CM was defined as the presence of coronary artery disease (CAD) and left ventricular ejection fraction ≤ 30%. Results: Despite no significant difference in CAD and VT occurrence between CRI and non‐CRI groups in the overall population, there was a significantly higher mortality rate in the CRI group (P < 0.0001). Conclusion: CRI is a significant independent predictor of mortality in ICD recipients. Further investigation is needed to determine whether prevention, early detection, and more aggressive intervention in the treatment of CRI will reduce the incidence of mortality in this population.
- 24 January 2006
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 29 (1) , 9-14
Suboptimal Glycemic Control, Independently of QT Interval Duration, Is Associated with Increased Risk of Ventricular Arrhythmias in a High‐Risk Population
Background: Although cardiovascular disease is the leading cause of mortality in diabetic patients, little is known about the impact of glycemic control on ventricular tachycardia (VT). Objective: To investigate whether hemoglobin A1c (HbA1c) is associated with increased incidence of VT. Methods: A retrospective study of 336 implantable cardioverter‐defibrillator patients (both diabetes mellitus (DM) and non‐DM) was conducted. Results: HbA1c levels between 8% and 10% had a significant association with spontaneous VT, but not with QT/QTc. Conclusions: Glycemic index is a significant predictor of spontaneous VT, independently of QT interval. Optimal glycemic control may help reduce occurrence of VT and sudden cardiac death in high‐risk DM patients.
- 24 January 2006
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 29 (1) , 9-14
Suboptimal Glycemic Control, Independently of QT Interval Duration, Is Associated with Increased Risk of Ventricular Arrhythmias in a High‐Risk Population
Background: Although cardiovascular disease is the leading cause of mortality in diabetic patients, little is known about the impact of glycemic control on ventricular tachycardia (VT). Objective: To investigate whether hemoglobin A1c (HbA1c) is associated with increased incidence of VT. Methods: A retrospective study of 336 implantable cardioverter‐defibrillator patients (both diabetes mellitus (DM) and non‐DM) was conducted. Results: HbA1c levels between 8% and 10% had a significant association with spontaneous VT, but not with QT/QTc. Conclusions: Glycemic index is a significant predictor of spontaneous VT, independently of QT interval. Optimal glycemic control may help reduce occurrence of VT and sudden cardiac death in high‐risk DM patients.